1 recruiting, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Progressive Multifocal Leukoencephalopathy: new trials by email Literature Review of Progressive Multifocal Leukoencephalopathy trials Research Report on Progressive Multifocal Leukoencephalopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy 89 Zr-Df-crefmirlimab - Progressive Multifocal Leukoencephalopathy, Multiple Sclerosis | Phase 1 | Recruiting | National Institute of Neurological Disorders and Stroke (NINDS) | 15 | 2023-10-19 | 2026-06-05 |
| Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML) mefloquine - Progressive Multifocal Leukoencephalopathy | Phase 1 / Phase 2 | Terminated | Biogen | 37 | 2009-01-01 | 2014-07-31 |
Leukoencephalopathy, Progressive Multifocal (2) · Central Nervous System Diseases (1) · Multiple Sclerosis (1)
Brain Diseases (2) · Central Nervous System Infections (2) · Central Nervous System Viral Diseases (2) · DNA Virus Infections (2) · Demyelinating Diseases (2) · Encephalitis (2) · Encephalitis, Viral (2) · Infections (2) · Infectious Encephalitis (2) · Leukoencephalopathies (2) · Nervous System Diseases (2) · Neuroinflammatory Diseases (2) · Polyomavirus Infections (2) · Slow Virus Diseases (2) · Virus Diseases (2)
Mefloquine (1)
Biogen (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1)
United States (2) · Brazil (1) · Germany (1) · Italy (1) · Spain (1)